Company Filing History:
Years Active: 1997-2000
Title: Marlene A. Jacobson: Innovator in Adenosine Receptor Research
Introduction
Marlene A. Jacobson is a distinguished inventor based in Elkins Park, PA (US). She has made significant contributions to the field of biochemistry, particularly in the study of human adenosine receptors. With a total of 5 patents to her name, Jacobson's work has advanced our understanding of these critical receptors.
Latest Patents
Jacobson's latest patents focus on recombinant human adenosine receptors A1, A2a, A2b, and A3. These inventions involve the preparation of these receptors through cDNA cloning and polymerase chain reaction techniques. Additionally, her patents include expression systems for these receptors and assays utilizing these systems. The recombinant adenosine receptors can be employed in assays to identify and evaluate entities that bind to or enhance binding to adenosine receptors.
Career Highlights
Marlene A. Jacobson is currently associated with Merck & Company, Inc., where she continues her innovative research. Her work has been pivotal in the development of new therapeutic approaches targeting adenosine receptors, which play a vital role in various physiological processes.
Collaborations
Throughout her career, Jacobson has collaborated with notable colleagues, including Robert G. Johnson and Christopher A. Salvatore. These collaborations have further enriched her research and contributed to the advancement of knowledge in her field.
Conclusion
Marlene A. Jacobson is a prominent figure in the realm of adenosine receptor research, with a strong portfolio of patents and impactful collaborations. Her contributions continue to shape the future of biochemistry and therapeutic development.